Findings from a retrospective analysis show that montelukast prophylaxis significantly reduced rituximab infusion-related reactions, particularly among patients receiving treatment for oncology indications.
Sian Behrendt-McLeroy, PharmD, MS
Advertisement
Articles by Sian Behrendt-McLeroy, PharmD, MS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
2
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
3
Study Reveals a Widening Gap Between Buprenorphine Prescribing and Dispensing
4
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
5